Impact of Astroglial Connexins on Modafinil Pharmacological Properties
Author(s) -
Adeline Duchêne,
Magali Perier,
Yan Zhao,
Xinhe Liu,
Julien Thomasson,
Frédéric Chauveau,
Christophe Piérard,
D. Lagarde,
Christèle Picoli,
Tiffany Jeanson,
Franck Mouthon,
Yves Dauvilliers,
Christian Giaume,
JianSheng Lin,
Mathieu Charvériat
Publication year - 2016
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.5665/sleep.5854
Subject(s) - modafinil , pharmacology , narcolepsy , connexin , neuroscience , flecainide , medicine , chemistry , psychology , gap junction , biochemistry , intracellular , atrial fibrillation
Modafinil is a non-amphetaminic wake-promoting compound used as therapy against sleepiness and narcolepsy. Its mode of action is complex, but modafinil has been recently proposed to act as a cellular-coupling enhancer in glial cells, through modulation of gap junctions constituted by connexins. The present study investigated in mice the impact of connexins on the effects of modafinil using connexin inhibitors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom